SAN FRANCISCO, Dec. 12, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (Nasdaq: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced ...
SAN FRANCISCO, March 16, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has ...
SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (Nasdaq: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced ...
SAN FRANCISCO, May 7, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the U.S. Food ...
Denise Bevers is a founder and chief operating officer of Kindred Biosciences Inc., a Burlingame company developing drugs for cats, dogs and horses. A drug initially developed as an antidepressant for ...
Q: Elmo, my elderly cat, is losing his appetite and getting thinner. A friend told me about a drug her veterinarian prescribed when her cat lost his appetite that helped him regain weight. What is the ...
KindredBio recorded Mirataz ® (mirtazapine transdermal ointment) net product revenues of $1.3 million in the fourth quarter, which is more than double third quarter net product revenues of $0.6 ...
U.S. Commerce Secretary Howard Lutnick said on Sunday he was confident the United States can secure a trade deal with the European Union, but August 1 is a hard deadline for tariffs to kick in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results